Glycine-extended gastrin inhibits apoptosis in Barrett's oesophageal and oesophageal adenocarcinoma cells through JAK2/STAT3 activation

Journal of Molecular Endocrinology

Volumn 42, Issue 4, 2009, Pages 305-318

  Beales, Ian L P ^a,b   Ogunwobi, Olorunseun O ^b  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; CHOLECYSTOKININ RECEPTOR; CYCLOOXYGENASE 2; GASTRIN; GLYCINE; GLYCINE EXTENDED GASTRIN; JANUS KINASE 2; MESSENGER RNA; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; SMALL INTERFERING RNA; STAT3 PROTEIN; SURVIVIN; UNCLASSIFIED DRUG; GLYCINE EXTENDED GASTRIN 17; GLYCINE-EXTENDED GASTRIN 17; JAK2 PROTEIN, HUMAN; PROSTAGLANDIN SYNTHASE INHIBITOR; STAT3 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; BARRETT ESOPHAGUS; CANCER CELL CULTURE; CARCINOGENICITY; CELL LEVEL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ESOPHAGEAL ADENOCARCINOMA; GASTRIN RELEASE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; RNA INTERFERENCE; ADENOCARCINOMA; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; ESOPHAGUS TUMOR; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ADENOCARCINOMA; APOPTOSIS; BARRETT ESOPHAGUS; CELL LINE, TUMOR; CYCLOOXYGENASE INHIBITORS; ENZYME ACTIVATION; ESOPHAGEAL NEOPLASMS; GASTRINS; HUMANS; JANUS KINASE 2; RECEPTORS, CHOLECYSTOKININ; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 67449132488     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1677/JME-08-0096     Document Type: Article

References (68)

1. Abdalla SI, Lao-Sirieix P, Novelli MR, Lovat LB, Sanderson IR & Fitzgerald RC 2004 Gastrin-induced cyclooxygenase-2 expression in Barrett's carcinogenesis. Clinical Cancer Research 10 4784-4792.
2. Beales IL & Ogunwobi O 2006 Glycine-extended gastrin inhibits apoptosis in colon cancer cells via separate activation of Akt and JNK pathways. Molecular and Cellular Endocrinology 247 140-149.
3. Beales IL & Ogunwobi OO 2007 Leptin synergistically enhances the anti-apoptotic and growth-promoting effects of acid in OE33 oesophageal adenocarcinoma cells in culture. Molecular and Cellular Endocrinology 274 60-68.
4. Blaskovich MA, Sun J, Cantor A, Turkson J, Jove R & Sebti SM 2003 Discovery of JSI-124 (cucurbitacin I), a selective janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Cancer Research 63 1270-1279.
5. Bowman T, Garcia R, Turkson J & Jove R 2000 STATs in oncogenesis. Oncogene 19 2474-2488.
6. Buchan AM, Grant S & Freeman HJ 1985 Regulatory peptides in Barrett's oesophagus. Journal of Pathology 146 227-234.
7. Buttar NS & Wang KK 2004 Mechanisms of disease: carcinogenesis in Barrett's esophagus. Nature Clinical Practice. Gastroenterology and Hepatology 1 106-112.
8. Buttar NS, Wang KK, Anderson MA, Dierkhising RA, Pacifico RJ, Krishnadath KK & Lutzke LS 2002a The effect of selective cyclooxygenase-2 inhibition in Barrett's esophagus epithelium: an in vitro study. Journal of National Cancer Institute 94 422-429.
9. Buttar NS, Wang KK, Leontovich O, Westcott JY, Pacifico RJ, Anderson MA, Krishnadath KK, Lutzke LS & Burgart LJ 2002b Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus. Gastroenterology 122 1101-1112.
10. Cheong E, Igali L, Harvey I, Mole M, Lund E, Johnson IT & Rhodes M 2003 Cyclo-oxygenase-2 expression in Barrett's oesophageal carcinogenesis: an immunohistochemical study. Alimentary Pharmacology and Therapeutics 17 379-386.
11. Clerc P, Dufresne M, Saillan C, Chastre E, Andre T, Escrieut C, Kennedy K, Vaysse N, Gespach C & Fourmy D 1997 Differential expression of the CCK-A and CCK-B/gastrin receptor genes in human cancers of the esophagus, stomach and colon. International Journal Cancer 72 931-936.
12. Cobb S, Wood T, Ceci J, Varro A, Velasco M & Singh P 2004 Intestinal expression of mutant and wild-type progastrin significantly increases colon carcinogenesis in response to azoxymethane in transgenic mice. Cancer 100 1311-1323.
13. Del Valle J, Sugano K & Yamada T 1987 Progastrin and its glycine-extended posttranslational processing intermediates in human gastrointestinal tissues. Gastroenterology 92 1908-1912.
14. Del Valle J, Sugano K & Yamada T 1989 Glycine-extended processing intermediates of gastrin and cholecystokinin in human plasma. Gastroenterology 97 1159-1163.
15. Dockray GJ, Hamer C, Evans D, Varro A & Dimaline R 1991 The secretory kinetics of the G cell in omeprazole-treated rats. Gastroenterology 100 1187-1194.
16. Dockray GJ, Varro A, Dimaline R & Wang T 2001 The gastrins: their production and biological activities. Annual Review of Physiology 63 119-139.
17. Dvorak K, Chavarria M, Payne CM, Ramsey L, Crowley-Weber C, Dvorakova B, Dvorak B, Bernstein H, Holubec H, Sampliner RE et al. 2007 Activation of the interleukin-6/STAT3 antiapoptotic pathway in esophageal cells by bile acids and low pH: relevance to barrett's esophagus. Clinical Cancer Research 13 5305-5313.
18. Ferrand A, Bertrand C, Portolan G, Cui G, Carlson J, Pradayrol L, Fourmy D, Dufresne M, Wang TC & Seva C 2005 Signaling pathways associated with colonic mucosa hyperproliferation in mice over-expressing gastrin precursors. Cancer Research 65 2770-2777.
19. Ferrand A, Kowalski-Chauvel A, Pannequin J, Bertrand C, Fourmy D, Dufresne M & Seva C 2006 Glycine-extended gastrin activates two independent tyrosine-kinases in upstream of p85/p110 phosphatidylinositol 3-kinase in human colonic tumour cells. World Journal of Gastroenterology 12 1859-1864.
20. Fox JG, Rogers AB, Ihrig M, Taylor NS, Whary MT, Dockray G, Varro A & Wang TC 2003 Helicobacter pylori-associated gastric cancer in INS-GAS mice is gender specific. Cancer Research 63 942-950.
21. Grabowska AM & Watson SA 2007 Role of gastrin peptides in carcinogenesis. Cancer Letters 257 1-15.
22. Grabowska AM, Hughes J & Watson SA 2007 Use of interfering RNA to investigate the role of endogenous gastrin in the survival of gastrointestinal cancer cells. British Journal of Cancer 96 464-473.
23. Gritsko T, Williams A, Turkson J, Kaneko S, Bowman T, Huang M, Nam S, Eweis I, Diaz N, Sullivan D et al. 2006 Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Clinical Cancer Research 12 11-19.
24. Grunberger T, Demin P, Rounova O, Sharfe N, Cimpean L, Dadi H, Freywald A, Estrov Z & Roifman CM 2003 Inhibition of acute lymphoblastic and myeloid leukemias by a novel kinase inhibitor. Blood 102 4153-4158.
25. Haigh CR, Attwood SE, Thompson DG, Jankowski JA, Kirton CM, Pritchard DM, Varro A & Dimaline R 2003 Gastrin induces proliferation in Barrett's metaplasia through activation of the CCK2 receptor. Gastroenterology 124 615-625.
26. Hardy MM, Blomme EA, Lisowski A, Chinn KS, Jones A, Harmon JM, Opsahl A, Ornberg RL & Tripp CS 2003 Selective cyclooxygenase-2 inhibition does not alter keratinocyte wound responses in the mouse epidermis after abrasion. Journal of Pharmacological and Experimental Therapeutics 304 959-967.
27. Harris JC, Clarke PA, Awan A, Jankowski J & Watson SA 2004 An antiapoptotic role for gastrin and the gastrin/CCK-2 receptor in Barrett's esophagus. Cancer Research 64 1915-1919.
28. He H, Yim M, Liu KH, Cody SC, Shulkes A & Baldwin GS 2008 Involvement of G proteins of the Rho family in the regulation of Bcl-2-like protein expression and caspase 3 activation by gastrins. Cell Signalling 20 83-93.
29. Hoda MR, Keely SJ, Bertelsen LS, Junger WG, Dharmasena D & Barrett KE 2007 Leptin acts as a mitogenic and antiapoptotic factor for colonic cancer cells. British Journal of Surgery 94 346-354.
30. Iwase K, Evers BM, Hellmich MR, Guo YS, Higashide S, Kim HJ & Townsend CM Jr 1997 Regulation of growth of human gastric cancer by gastrin and glycine-extended progastrin. Gastroenterology 113 782-790.
31. Jiang H, Yu J, Guo H, Song H & Chen S 2008 Upregulation of survivin by leptin/STAT3 signaling in MCF-7 cells. Biochemical and Biophysical Research Communication 368 1-5.
32. Johnson JD, Ahmed NT, Luciani DS, Han Z, Tran H, Fujita J, Misler S, Edlund H & Polonsky KS 2003 Increased islet apoptosis in Pdx1+/-mice. Journal Clinical Investigation 111 1147-1160.
33. Koh TJ, Dockray GJ, Varro A, Cahill RJ, Dangler CA, Fox JG & Wang TC 1999 Overexpression of glycine-extended gastrin in transgenic mice results in increased colonic proliferation. Journal of Clinical Investigation 103 1119-1126.
34. Koh TJ, Bulitta CJ, Fleming JV, Dockray GJ, Varro A & Wang TC 2000 Gastrin is a target of the beta-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposis. Journal of Clinical Investigation 106 533-539.
35. Koh TJ, Field JK, Varro A, Liloglou T, Fielding P, Cui G, Houghton J, Dockray GJ & Wang TC 2003 Glycine-extended gastrin promotes the growth of lung cancer. Cancer Research 64 196-201.
36. Konturek PC, Nikiforuk A, Kania J, Raithel M, Hahn EG & Muhldorfer S 2004 Activation of NFkappaB represents the central event in the neoplastic progression associated with Barrett's esophagus: a possible link to the inflammation and overexpression of COX-2, PPARgamma and growth factors. Digestive Diseases and Sciences 49 1075-1083.
37. Langmesser S, Cerezo-Guisado MI, Lorenzo MJ, Garcia-Marin LJ & Bragado MJ 2007 CCK1, and 2 receptors are expressed in immortalized rat brain neuroblasts: intracellular signals after cholecystokinin stimulation. Journal of Cellular Biochemistry 100 851-864.
38. Muerkoster S, Isberner A, Arlt A, Witt M, Reimann B, Blaszczuk E, Werbing V, Folsch UR, Schmitz F & Schafer H 2005 Gastrin suppresses growth of CCK2 receptor expressing colon cancer cells by inducing apoptosis in vitro and in vivo. Gastroenterology 129 952-968.
39. Nemeth J, Varro A, Bridson J, Walker R & Dockray GJ 1992 Increased tissue concentrations of the gastrin precursor in patients treated with omeprazole. European Journal of Clinical Investigation 22 638-644.
40. Ogunwobi OO & Beales IL 2006 Glycine-extended gastrin stimulates proliferation and inhibits apoptosis in colon cancer cells via cyclooxygenase-independent pathways. Regulatory Peptides 134 1-8.
41. Ogunwobi O, Mutungi G & Beales IL 2006 Leptin stimulates proliferation and inhibits apoptosis in Barrett's esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prostaglandin-E2-mediated transactivation of the epidermal growth factor receptor and c-Jun NH2-terminal kinase activation. Endocrinology 147 4505-4516.
42. Ogunwobi OO & Beales IL 2007a The anti-apoptotic and growth stimulatory actions of leptin in human colon cancer cells involves activation of JNK mitogen activated protein kinase, JAK2 and PI3 kinase/ Akt. International Journal of Colorectal Disease 22 401-409.
43. Ogunwobi OO & Beales IL 2007b Cyclo-oxygenase-independent inhibition of apoptosis and stimulation of proliferation by leptin in human colon cancer cells. Digestive Diseases and Sciences 52 1934-1945.
44. Ogunwobi OO & Beales ILP 2008a Leptin stimulates the proliferation of human oesophageal adenocarcinoma cells via HB-EGF and TGFα mediated transactivation of the epidermal growth factor receptor. British Journal of Biomedical Science 65 121-127.
45. Ogunwobi OO & Beales IL 2008b Globular adiponectin, acting via adiponectin receptor-1, inhibits leptin-stimulated oesophageal adenocarcinoma cell proliferation. Molecular and Cellular Endocrinology 285 43-50.
46. Ogunwobi OO & Beales ILP 2008c Glycine-extended gastrin stimulates proliferation via JAK2- and Akt-dependent NF-κB activation in Barrett's oesophageal adenocarcinoma cells. Molecular and Cellular Endocrinology 296 94-102.
47. Ottewell PD, Varro A, Dockray GJ, Kirton CM, Watson AJ, Wang TC & Dimaline R 2005 COOH-terminal 26-amino acid residues of progastrin are sufficient for stimulation of mitosis in murine colonic epithelium in vivo. American Journal of Physiology. Gastrointestinal and Liver Physiology 288 G541-G549.
48. Palanca-Wessels MC, Klingelhutz A, Reid BJ, Norwood TH, Opheim KE, Paulson TG, Feng Z & Rabinovitch PS 2003 Extended lifespan of Barrett's esophagus epithelium transduced with the human telomerase catalytic subunit: a useful in vitro model. Carcinogenesis 24 1183-1190.
49. Ramamoorthy S, Stepan V & Todisco A 2004 Intracellular mechanisms mediating the anti-apoptotic action of gastrin. Biochemical and Biophysical Research Communication 323 44-48.
50. Rengifo-CamW, Umar S, Sarkar S & Singh P 2007 Antiapoptotic effects of progastrin on pancreatic cancer cells are mediated by sustained activation of nuclear factor-{kappa}B. Cancer Research 67 7266-7274.
51. Rouet-Benzineb P, Aparicio T, Guilmeau S, Pouzet C, Descatoire V, Buyse M & Bado A 2004 Leptin counteracts sodium butyrate-induced apoptosis in human colon cancer HT-29 cells via NF-kappaB signaling. Journal of Biological Chemistry 279 16495-16502.
52. Russo VC, Metaxas S, Kobayashi K, Harris M & Werther GA 2004 Antiapoptotic effects of leptin in human neuroblastoma cells. Endocrinology 145 4103-4112.
53. Sanduleanu S, Stridsberg M, Jonkers D, Hameeteman W, Biemond I, Lundqvist G, Lamers C & Stockbrugger RW 1999 Serum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: a case-control study. Alimentary Pharmacology and Therapeutics 13 145-153.
54. Schust J, Sperl B, Hollis A, Mayer TU & Berg T 2006 Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. Chemistry and Biology 13 1235-1242.
55. Selvendiran K, Koga H, Ueno T, Yoshida T, Maeyama M, Torimura T, Yano H, Kojiro M & Sata M 2006 Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells: an implication for the antitumor potential of flavonoids. Cancer Research 66 4826-4834.
56. Seva C, Dickinson CJ & Yamada T 1994 Growth-promoting effects of glycine-extended progastrin. Science 265 410-412.
57. Singh P, Wu H, Clark C & Owlia A 2007 Annexin II binds progastrin and gastrin-like peptides, and mediates growth factor effects of autocrine and exogenous gastrins on colon cancer and intestinal epithelial cells. Oncogene 26 425-440.
58. Souza RF, Shewmake K, Beer DG, Cryer B & Spechler SJ 2000 Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells. Cancer Research 60 5767-5772.
59. Souza RF, Shewmake K, Terada LS & Spechler SJ 2002 Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus. Gastroenterology 122 299-307.
60. Stepan VM, Sawada M, Todisco A & Dickinson CJ 1999 Glycine-extended gastrin exerts growth-promoting effects on human colon cancer cells. Molecular Medicine 5 147-159.
61. Stepan V, Ramamoorthy S, Pausawasdi N, Logsdon CD, Askari FK & Todisco A 2004 Role of small GTP binding proteins in the growth-promoting and antiapoptotic actions of gastrin. American Journal of Physiology-Gastrointestinal and Liver Physiology 287 G715-G725.
62. Sugano K, Park J, Dobbins WO & Yamada T 1987 Glycine-extended progastrin processing intermediates: accumulation and cosecretion with gastrin. American Journal of Physiology 253 G502-G507.
63. Todisco A, Takeuchi Y, Urumov A, Yamada J, Stepan VM & Yamada T 1997 Molecular mechanisms for the growth factor action of gastrin. American Journal of Physiology 273 G891-G898.
64. Todisco A, Ramamoorthy S, Witham T, Pausawasdi N, Srinivasan S, Dickinson CJ, Askari FK & Krametter D 2001 Molecular mechanisms for the antiapoptotic action of gastrin. American Journal of Physiology-Gastrointestinal and Liver Physiology 280 G298-G307.
65. Turkson J, Ryan D, Kim JS, Zhang Y, Chen Z, Haura E, Laudano A, Sebti S, Hamilton AD & Jove R 2001 Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation. Journal Biological Chemistry 276 45443-45455.
66. Vallbohmer D, Peters JH, Oh D, Kuramochi H, Shimizu D, Demeester SR, Hagen JA, Chandrasoma PT, Danenberg KD, DeMeester TR et al. 2005 Survivin, a potential biomarker in the development of Barrett's adenocarcinoma. Surgery 138 701-706.
67. van der Woude CJ, Jansen PL, Tiebosch AT, Beuving A, Homan M, Kleibeuker JH & Moshage H 2002 Expression of apoptosis-related proteins in Barrett's metaplasia-dysplasia-carcinoma sequence: a switch to a more resistant phenotype. Human Pathology 33 686-692.
68. Wang TC, Dangler CA, Chen D, Goldenring JR, Koh T, Raychowdhury R, Coffey RJ, Ito S, Varro A, Dockray GJ et al. 2000 Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology 118 36-47.